Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Clinical trial NCT00129948 · TERMINATED
Trial details
- NCT number
- NCT00129948
- Sponsor
- SGX Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.